IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Inovio Pharmaceuticals, Inc.
Symbol: INO
Price: Last trade $9.86
Trade Date: 4/30
Shares: 7.1 million
Underwriter(s) Piper Jaffray, Stifel
Rating=Subscription Needed
Company: Advaxis, Inc.
Symbol: ADXS
Price: Last trade $19.89
Trade Date: 4/30
Shares: 2.5 million
Underwriter(s) Jefferies, Barclays, Guggenheim Securities
Rating=Subscription Needed
Company: Scorpio Tankers Inc.
Symbol: STNG
Price: Last trade $10.00
Trade Date: 4/30
Shares: 15 million
Underwriter(s) UBS Securities, Clarksons PLC
Co Manager(s) Evercore, Nomura Securities, Stifel
Rating=Subscription Needed
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish